Sevelamer Carbonate Powder, For Suspension
Product Images NDC 69452-127

10 FDA label images from Bionpharma Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 69452-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Structure Of Sevelamer Carbonate (Structure 1)

Figure 1: Structure Of Sevelamer Carbonate (Structure 1)
Chemical structure diagram of Sevelamer Carbonate, showing polymeric chains with ammonium groups (NH3+, NH2), bicarbonate ion (HCO3-), and additional amine and hydroxyl groups in the polymer structure.*
FDA Label Image

Image Description (Figure1)

Image Description (Figure1)
A forest plot depicting subgroup analysis results for Sevelamer Carbonate versus placebo. The y-axis lists subgroups by screening BSA, baseline serum phosphorus, age, and dialysis status. The x-axis shows the least squares mean difference with 95% confidence intervals, indicating effects favoring Sevelamer Carbonate or placebo.*
FDA Label Image

Figure 3 (Figure 2)

Figure 3 (Figure 2)
This chart depicts the percentage of patients achieving various reductions in serum phosphorus levels (mg/dL) from baseline, comparing Sevelamer Hydrochloride and an active control. The x-axis shows reduction in serum phosphorus, with a range from worsened increase to improved reduction, while the y-axis shows the percentage of patients with at least a given reduction. Both treatments show a similar trend in patient response.*
FDA Label Image

Figure 4: Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Figure 3)

Figure 4: Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Figure 3)
Line graph showing phosphorus change from baseline over study weeks (0 to 52) comparing Sevelamer Hydrochloride and an Active-Control. The y-axis represents phosphorus change values from -5 to 2, with Sevelamer Hydrochloride depicted by solid black circles and Active-Control by red open squares. The graph indicates trends of phosphorus levels over time for two treatments.*
FDA Label Image

0-8-packet-front (0 8g Packet Front)

0-8-packet-front (0 8g Packet Front)
Label for Sevelamer Carbonate oral suspension powder, 0.8 g strength, lemon flavor. The label includes the NDC number 69452-126-60 and states Rx only. The product is labeled by Bionpharma Inc.*
FDA Label Image

0-8-packet-back (0 8g Packet Back)

0-8-packet-back (0 8g Packet Back)
This image shows a text panel with directions and handling instructions for Sevelamer Carbonate powder for suspension, 0.8 g per packet. It describes how to prepare the suspension by mixing the packet contents with water, storage conditions, and safety warnings. The labeler is Bionpharma Inc., with distribution and manufacturing details included.*
FDA Label Image

0-8-carton (0 8g Carton)

0-8-carton (0 8g Carton)
Packaging label for Sevelamer Carbonate For Oral Suspension, 0.8 g packets, lemon flavor. Contains 90 packets. Labeler is Bionpharma Inc. Directions indicate mixing each packet with at least 1 ounce of water before drinking. The label includes storage instructions and inactive ingredients. Barcode and manufacturing details are shown, stating the product is made in India.*
FDA Label Image

2-4-packet-front (2 4g Packet Front)

2-4-packet-front (2 4g Packet Front)
Label for Sevelamer Carbonate oral suspension powder, 2.4 g strength, lemon flavor. The label displays the NDC code 69452-127-60 and indicates the product is Rx only. The manufacturer is Bionpharma Inc.*
FDA Label Image

2-4-packet-back (2 4g Packet Back)

2-4-packet-back (2 4g Packet Back)
Sevelamer Carbonate powder for suspension packet label showing a sealed tear line for opening. Each packet contains 2.4 g of sevelamer carbonate. Directions instruct to empty the packet into at least 2 ounces (4 tablespoons) of water, stir well, and consume within 30 minutes. The label states storage conditions, manufacturer Bionpharma Inc., and includes a barcode. Lot and expiration fields are blank.*
FDA Label Image

2-4-carton (2 4g Carton)

2-4-carton (2 4g Carton)
Carton label for Sevelamer Carbonate For Oral Suspension 2.4 g packets, lemon flavor, containing 90 packets per carton. The label shows dosing directions and inactive ingredients. Distributed by Bionpharma Inc., Princeton, NJ, made in India. The product is Rx only and intended for oral use as a powder for suspension.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.